FindTrial
Sign In

Botulinum toxin A injection in the prevention of cicatricial hyperplasia of facial surgical incision: A prospective, group controlled, randomized, double-blind trial

The effect of botulinum toxin A injection in the prevention of cicatricial hyperplasia of facial surgical incision

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064222
Enrollment
Unknown
Registered
2022-09-30
Start date
2022-09-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scar

Interventions

Experimental group:Botulinum toxin type A (normal saline diluted to 25Units/ml, lanzhou hengli) was injected immediately after surgical suture, and the injection dose was 1Unit per 1mm wound, 0.5cm aw
Control group:Inject the appropriate amount of saline

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Facial surgery is planned; 2. Sign the informed consent form, be willing to accept the group control test and cooperate with long-term follow-up; 3. No other systemic diseases.

Exclusion criteria

Exclusion criteria: 1. Those who are known to be allergic to botulinum toxin; 2. Botulinum toxin injection within 6 months; 3. Myasthenia gravis patients; 4. Fitzpatrick skin type is V-VI; 5. The investigator believes that the patient is not suitable for this study

Design outcomes

Primary

MeasureTime frame
Visual analogue scale;—

Secondary

MeasureTime frame
Vancouver Scar Scale;Scar width;—

Countries

China

Contacts

Public ContactXiaoXi Lin

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine

linxiaoxi@126.com+86 13701997136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026